Harvard Bioscience (HBIO) Other Non Operating Income (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Other Non Operating Income of -$405000.0 for Q1 2026, down 109.84% year-over-year from $4.1 million in Q1 2025, and down 122.01% quarter-over-quarter from $1.8 million in Q4 2025.
Harvard Bioscience (HBIO) Other Non Operating Income (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Other Non Operating Income for 17 consecutive years, with -$405000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income fell 109.84% year-over-year to -$405000.0; the TTM figure through Mar 2026 stood at $426000.0 (up 213.3% YoY), while the FY2025 annual figure was $507000.0, up 256.0% from the prior year.
- Other Non Operating Income declined to -$405000.0 in Q1 2026 per HBIO's latest filing, from $1.8 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.8 million in Q4 2025 and bottomed at -$644000.0 in Q2 2025.
- Historically, Other Non Operating Income has averaged -$1000.0 across 5 years, with a median of -$179000.0 in 2022.
- Annual changes were most pronounced in 2023 — Other Non Operating Income surged 453.85% — and 2024, when it plunged 1251.11%.
- Harvard Bioscience's Other Non Operating Income stood at $465000.0 in 2022, then sank by 171.4% to -$332000.0 in 2023, then surged by 255.42% to $516000.0 in 2024, then surged by 256.59% to $1.8 million in 2025, then tumbled by 122.01% to -$405000.0 in 2026.
- Business Quant data shows HBIO's Other Non Operating Income at -$405000.0 in Q1 2026, $1.8 million in Q4 2025, and -$365000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -125,000.00 |
| Mar 31, 2026 | -405,000.00 |
| Dec 31, 2025 | 1.84 Mn |
| Sep 30, 2025 | -365,000.00 |
| Jun 30, 2025 | -644,000.00 |
| Mar 31, 2025 | -193,000.00 |
| Dec 31, 2024 | 516,000.00 |
| Sep 30, 2024 | -518,000.00 |
| Jun 30, 2024 | -181,000.00 |
| Mar 31, 2024 | -142,000.00 |
| Dec 31, 2023 | -332,000.00 |
| Sep 30, 2023 | 45,000.00 |
| Jun 30, 2023 | -372,000.00 |
| Mar 31, 2023 | 432,000.00 |
| Dec 31, 2022 | 465,000.00 |
| Sep 30, 2022 | -179,000.00 |
| Jun 30, 2022 | -62,000.00 |
| Mar 31, 2022 | 78,000.00 |
| Dec 31, 2021 | 5.58 Mn |
| Sep 30, 2021 | -130,000.00 |